Patients who are already screened and have abnormal screening results that are not highly
suspicious should be delayed for 6-8 weeks. The feasibility of an assessment for a highly …

Dr Heller is an associate professor in the breast imaging section of the Department of
Radiology at the New York University Grossman School of Medicine. Her research interests …

Abstract The novel SARS-CoV2 (COVID-19) pandemic has had a major impact on breast
radiology practices. Initially, nonessential imaging studies, including screening …

During the COVID-19 pandemic, breast imaging must be performed using safe practices.
Balancing the need to avoid delays in the diagnosis of breast cancer while avoiding …

The COVID-19 pandemic has widely disrupted healthcare systems throughout the world. On
March 18th, 2020 at the onset of the COVID-19 pandemic all breast screening throughout …

On December 2019, a viral pneumonia known as coronavirus disease 2019 (COVID-19)
was reported in China and has spread rapidly throughout the world. The official …

The emergence of the COVID-19 pandemic presented new and yet uncharted challenges to
the field of radiology, and consequently to breast imaging as a subspecialty. Maintaining a …

Coronavirus disease 2019 (COVID-19) is a novel respiratory virus first identified in Wuhan,
China, in late 2019. Symptoms vary from asymptomatic (particularly at younger ages) to …

Abstract The Italian College of Breast Radiologists by the Italian Society of Medical
Radiology (SIRM) provides recommendations for breast care provision and procedural …

Purpose The aim of this study was to quantify the initial decline and subsequent rebound in
breast cancer screening metrics throughout the coronavirus disease 2019 (COVID-19) …